<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Genet</journal-id><journal-id journal-id-type="iso-abbrev">Front Genet</journal-id><journal-id journal-id-type="publisher-id">Front. Genet.</journal-id><journal-title-group><journal-title>Frontiers in Genetics</journal-title></journal-title-group><issn pub-type="epub">1664-8021</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32425988</article-id><article-id pub-id-type="pmc">7212409</article-id><article-id pub-id-type="doi">10.3389/fgene.2020.00423</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Identification of Immune Cell Landscape and Construction of a Novel Diagnostic Nomogram for Crohn&#x02019;s Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Hong</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/863347/overview"/></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chunqiu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Xiaoqi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Weiwei</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Mu-qing</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/777139/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Qiwei</given-names></name><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/723548/overview"/></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Zhenyu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yin</surname><given-names>Lu</given-names></name><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/863249/overview"/></contrib></contrib-group><aff><institution>Center for Difficult and Complicated Abdominal Surgery, Shanghai Tenth People&#x02019;s Hospital, Tongji University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Raya Khanin, Memorial Sloan Kettering Cancer Center, Weill Cornell Graduate School of Medical Sciences, Cornell University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Biju Issac, Leidos Biomedical Research, Inc., United States; Zongqiang Huang, First Affiliated Hospital of Zhengzhou University, China</p></fn><corresp id="c001">*Correspondence: Lu Yin, <email>yindalu@tongji.edu.cn</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to Bioinformatics and Computational Biology, a section of the journal Frontiers in Genetics</p></fn></author-notes><pub-date pub-type="epub"><day>29</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>423</elocation-id><history><date date-type="received"><day>05</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>03</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Chen, Chen, Yuan, Xu, Yang, Li, Shen and Yin.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Chen, Chen, Yuan, Xu, Yang, Li, Shen and Yin</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Crohn&#x02019;s disease (CD) has an increasing incidence and prevalence worldwide. The etiology of CD remains unclear and there is no gold standard for diagnosis. The dysregulated immune response and different infiltration status of immune cells are critical for CD pathogenesis; therefore, it is important to provide an overview of immune-cell alterations in CD and explore a novel method for auxiliary diagnosis. Here we analyzed microarray datasets from Gene Expression Omnibus (GEO), and an extended version of Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORTx) was utilized to estimate the fraction of 22 types of immune cells. Differentially expressed genes (DEGs) and a protein-protein interaction (PPI) network were identified, and we performed gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) to identify differentially regulated pathways in CD. Least absolute shrinkage and selection operator (LASSO) regression was conducted to filter features, and a diagnostic nomogram based on logistic regression was built and validated in an independent validation cohort. In the derivation cohort, we found a proportion of 17 immune-cell types to be significantly altered between CD and healthy controls and a total of 150 DEGs were identified, which were mostly related to the immune response. Among the 15 hub genes based on the PPI network, C-X-C chemokine ligand 8 (CXCL8) and interleukin-1B (IL-1B) showed the highest degree of interaction. Additionally, GSEA and GSVA identified five significantly enriched pathways, among which the nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway was critical in the CD development. Furthermore, six variables comprising of CXCL8, IL-1B, M1 macrophages, regulatory T cells, CD8<sup>+</sup> T cells, and plasma cells were identified by LASSO regression and incorporated into a logistic regression model. The nomogram displayed a good prediction, with a 0.915 area under the receiver operating curve (AUC) and a C-index of 0.915 [95% confidence interval (CI): 0.875&#x02013;0.955]. Similar results were found in the validation cohort, with an AUC of 0.884 and a 0.884 C-index (95% CI: 0.843&#x02013;0.924). These results provide novel <italic>in silico</italic> insight into cellular and molecular characteristics of CD and potential biomarkers for diagnosis and targeted therapy.</p></abstract><kwd-group><kwd>inflammatory bowel diseases</kwd><kwd>Crohn&#x02019;s disease</kwd><kwd>CIBERSORTx</kwd><kwd>immune cells</kwd><kwd>GSVA</kwd><kwd>nomogram</kwd></kwd-group><counts><fig-count count="8"/><table-count count="2"/><equation-count count="0"/><ref-count count="54"/><page-count count="14"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Inflammatory bowel diseases (IBDs) are disorders characterized by chronic inflammation that affects the digestive tract and includes the following two main components: ulcerative colitis (UC) and Crohn&#x02019;s disease (CD). CD can cause segmental and transmural damage in any section of the entire digestive tract, especially in the distal ileum and colon (<xref rid="B12" ref-type="bibr">Feuerstein and Cheifetz, 2017</xref>). There is currently no single gold standard for CD diagnosis; therefore a combination of endoscopic examination, histology, and clinical manifestation are recommended (<xref rid="B14" ref-type="bibr">Gomollon et al., 2017</xref>). However, in most cases, the clinical significance of CD histological hallmarks is low, and no medical treatments can cure CD completely (<xref rid="B11" ref-type="bibr">Feakins, 2013</xref>). Therefore, it is important to clarify the cellular and molecular mechanisms associated with CD pathogenesis and find novel intervention targets and explore potential biomarkers as diagnostic and prognostic indicators.</p><p>Numerous investigations of CD pathogenesis have focused on the interplay between environmental factors, genetics, gut microflora, and immune responses (<xref rid="B42" ref-type="bibr">Torres et al., 2017</xref>). As hallmarks of CD, the roles of immune cells in dysregulated intestinal immune responses are crucial and remain to be further elucidated (<xref rid="B10" ref-type="bibr">de Souza and Fiocchi, 2016</xref>). For example, T cells can cause mucosal damage in gut tissues by producing inflammatory cytokines, a process that can be blocked by treatment with the anti-&#x003b1;4 integrin antibody natalizumab (<xref rid="B25" ref-type="bibr">Neurath, 2014</xref>, <xref rid="B26" ref-type="bibr">2017</xref>). However, different subpopulations of T cells can differentially contributes (<xref rid="B37" ref-type="bibr">Smids et al., 2018</xref>). Traditional approaches for assessing tissue composition, such as immunohistochemistry and flow cytometry, are limited due to the difficulty in simultaneous identification of multiple immune-cell types, as well as their low throughput. Therefore, a comprehensive assessment of the heterogeneity of immune cells in CD occurrence is important.</p><p>With the development of microarray and high-throughput sequencing technologies, estimation of cell proportions from bulk tissues can be performed using genomics data via bioinformatics techniques (<xref rid="B36" ref-type="bibr">Shen-Orr and Gaujoux, 2013</xref>). Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) is a deconvolution algorithm that can analyze 22 distinct immune-cell subsets in complex tissues based on normalized bulk transcriptome profiles (<xref rid="B27" ref-type="bibr">Newman et al., 2015</xref>)and has been successfully used in different types of cancer (<xref rid="B31" ref-type="bibr">Peng et al., 2019</xref>; <xref rid="B48" ref-type="bibr">Yang et al., 2019</xref>; <xref rid="B51" ref-type="bibr">Zhang et al., 2019</xref>), as well as non-tumor diseases such as idiopathic pulmonary fibrosis and systemic lupus erythematosus (<xref rid="B21" ref-type="bibr">Liu et al., 2018</xref>; <xref rid="B30" ref-type="bibr">Panousis et al., 2019</xref>). In 2019, the developer of CIBERSORT introduced an updated version (CIBERSORTx) that provides more accurate portraits of tissue composition based on cell-expression signatures via single-cell experiments (<xref rid="B28" ref-type="bibr">Newman et al., 2019</xref>). These significant advances of the deconvolution algorithm provide the probability to comprehensively characterize infiltrating immune cells in CD.</p><p>In the present study, we performed a comprehensive analysis by integrating two expression profiling microarray datasets and exploring the proportion of intestinal immune-cell types for each individual using CIBERSORTx. After identifying differentially expressed genes (DEGs), we performed gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) to find signaling pathways involved in CD occurrence. We then constructed a multivariable logistic regression model based on the key features of this information and built a nomogram to provide a novel method for CD auxiliary diagnosis. Furthermore, an external cohort comprising of four microarray datasets was used for independent validation of the nomogram. The results provide in-depth insights into the cellular and molecular mechanisms related to clinical management of CD.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2.SS1"><title>Microarrays Datasets Collection</title><p>The raw data of microarray datasets [GSE112366 (<xref rid="B45" ref-type="bibr">VanDussen et al., 2018</xref>) and GSE75214 (<xref rid="B44" ref-type="bibr">Vancamelbeke et al., 2017</xref>)] were downloaded from the NCBI Gene Expression Omnibus (GEO) database (<xref rid="B2" ref-type="bibr">Barrett et al., 2013</xref>) and merged as a derivation cohort. The two datasets were based on the platforms of GPL13158 [(HT_HG-U133_Plus_PM) Affymetrix HT HG-U133 + PM Array Plate] and GPL6244 {[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]}, respectively. The dataset GSE112366 contains 141 CD samples without any treatment and 26 normal samples from the ileum. Another dataset (GSE75214) contains 75 CD samples and 22 normal samples obtained from the ileum or colon.</p></sec><sec id="S2.SS2"><title>Data Preprocessing and CIBERSORTx Estimation</title><p>Each expression matrix was extracted from the raw data using R package &#x0201c;affy&#x0201d; (<xref rid="B13" ref-type="bibr">Gautier et al., 2004</xref>) and then normalized and transformed into a log<sub>2</sub>-based logarithm by robust multi-array average algorithm (<xref rid="B16" ref-type="bibr">Irizarry et al., 2003</xref>). After matrix merging, the R package &#x0201c;sva&#x0201d; (<xref rid="B19" ref-type="bibr">Leek et al., 2012</xref>) and the function &#x0201c;combat&#x0201d; were used to remove the batch effects and other unnecessary variations. CIBERSORTx was employed to determine the proportion of each immune cell involved in CD patients and healthy individuals. The gene expression data was uploaded to the CIBERSORTx web portal<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>, and the algorithm was run using the LM22 signature for 100 permutations. The LM22 signature matrix defined 22 infiltrating immune-cell components, including subsets of macrophages, T cells, natural killer (NK) cells, mast cells, B cells, dendritic cells (DC), monocytes, plasma cells, neutrophils, and eosinophils (<xref rid="B27" ref-type="bibr">Newman et al., 2015</xref>). We used bulk-mode batch correction, and the output was in absolute mode according to the tutorial on the web site and reflects the absolute proportion of each cell type in the mixture. Only cases with a CIBERSORTx output <italic>P</italic> &#x0003c; 0.05 were chosen for further analysis. The Wilcoxon test was used to analyze differences in immune cell fractions between CD patients and healthy controls.</p></sec><sec id="S2.SS3"><title>Identification of DEGs and Functional Enrichment Analyses</title><p>The R package &#x0201c;limma&#x0201d; (<xref rid="B33" ref-type="bibr">Ritchie et al., 2015</xref>) was used to perform DEG analysis by comparing CD and healthy control groups. For DEG identification, the cut-off criteria of | log<sub>2</sub>FC| &#x0003e; 1 and adjusted <italic>P</italic> &#x0003c; 0.05 were regard as statistically significant. The biological function of DEGs was identified by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses by using the R package &#x0201c;clusterProfiler&#x0201d; (<xref rid="B50" ref-type="bibr">Yu et al., 2012</xref>). Fisher&#x02019;s exact test was employed, and the occurrence of false positives was corrected by Benjamini-Hochberg (B-H) multiple test correction method. An adjusted <italic>P</italic> &#x0003c; 0.05 was set as the cut-off criterion. The Search Tool for the Retrieval of Interacting Genes (STRING) online database<sup><xref ref-type="fn" rid="footnote2">2</xref></sup> was used to construct the protein-protein interaction (PPI) networks for the DEGs (<xref rid="B39" ref-type="bibr">Szklarczyk et al., 2019</xref>), with an interaction score &#x0003e;0.4 was regarded as statistically significant. Subsequently, the molecular interaction network was visualized using Cytoscape software (v 3.7.1) (<xref rid="B35" ref-type="bibr">Shannon et al., 2003</xref>). Furthermore, we used the Cytohubba plugin app within Cytoscape to calculate degree of interaction between DEGs and defined the top 15 genes as hub genes (<xref rid="B7" ref-type="bibr">Chin et al., 2014</xref>).</p></sec><sec id="S2.SS4"><title>GSEA and GSVA Analysis</title><p>GSEA is a calculation method to explore whether <italic>a priori</italic> defined genomes between two groups show significant differences. Therefore, we used GSEA software<sup><xref ref-type="fn" rid="footnote3">3</xref></sup> to evaluate the differentially enriched pathways between CD patients and healthy controls (<xref rid="B38" ref-type="bibr">Subramanian et al., 2005</xref>). The previously annotated gene set c2.cp.kegg.v6.2.symbols.gmt was chosen as the reference gene list. The results with a cut-off criterion of a nominal <italic>P</italic> &#x0003c; 0.05 were considered statistically significant. Furthermore, we performed GSVA to assess the underlying changes in pathway activity. This method is a non-parametric unsupervised method that transforms the genes of the sample matrix into predefined gene sets without <italic>a priori</italic> knowledge of experiment design (<xref rid="B15" ref-type="bibr">Hanzelmann et al., 2013</xref>). In the present study, we used the R package &#x0201c;GSVA&#x0201d; to calculate the scores for each patient based on previously defined gene sets of KEGG pathways. Subsequently, the R package limma was used to build linear models for comparing GSVA scores between CD patients and healthy controls and we defined pathways with a <italic>P</italic> &#x0003c; 0.05 and | log<sub>2</sub>FC| &#x02265; 0.2 as significantly altered.</p></sec><sec id="S2.SS5"><title>Co-expression Analysis and Construction of Predictive Nomogram</title><p>To elucidate interaction between immune cells, hub genes, and pathways in CD, we indentified co-expression patterns based on Spearman correlation analysis. To identify the immune cells critical to CD progression, we established criteria including a correlation coefficient &#x0003e;0.3 and a <italic>P</italic> &#x0003c; 0.05 and incorporated the immune cells and related hub genes and pathways into the least absolute shrinkage and selection operator (LASSO) regression model in order to select the optimal predictive features.</p><p>A multivariable logistic regression model and a nomogram were constructed by integrating the features with non-zero coefficients in LASSO regressionin in order to prevent model overfitting. Model sensitivity and specificity were evaluated by receiver operating characteristic (ROC) analyses. The calibration of the nomogram was assessed by comparing the observed actual diagnosis with the predicted probability by plotting a calibration curve. The C-index was measured to quantify the discriminative performance of the nomogram. The Pearson residuals plot was used to assess whether the model is fitted properly (<xref rid="B52" ref-type="bibr">Zhang, 2016</xref>).</p></sec><sec id="S2.SS6"><title>Validation of the Nomogram</title><p>The diagnostic nomogram was applied to an independent cohort comprising microarray datasets from the GEO [GSE3365 (<xref rid="B5" ref-type="bibr">Burczynski et al., 2006</xref>), GSE10616 (<xref rid="B18" ref-type="bibr">Kugathasan et al., 2008</xref>), GSE16879 (<xref rid="B1" ref-type="bibr">Arijs et al., 2009</xref>), and GSE102133 (<xref rid="B46" ref-type="bibr">Verstockt et al., 2019</xref>)] to evaluate the efficacy of model validation and prediction. These four datasets were based on the platforms GPL96 [(HG-U133A) Affymetrix Human Genome U133A Array], GPL5760 (Affymetrix GeneChip Human Genome U133 Plus 2.0 Array), GPL570 [(HG-U133_Plus_2) Affymetrix Human Genome U133 Plus 2.0 Array], GPL6244 [(HuGene-1_0-st) Affymetrix Human Gene 1.0 ST Array], respectively, and the features applied for validation were derived from the same method used in the derivation cohort (DEGs and CIBERSORTx).</p></sec></sec><sec id="S3"><title>Results</title><sec id="S3.SS1"><title>Composition of Immune Cells in CD and Normal Tissues</title><p>An overview of the workflow is shown in <xref ref-type="fig" rid="F1">Figure 1</xref> and the R code is available in <xref ref-type="supplementary-material" rid="DS1">Supplementary Data Sheet S1</xref>. The derivation cohort contained 216 CD tissue samples and 48 normal bowel tissue samples. Data before and after normalization were visualized in a boxplot and examined by principal component analysis (PCA), and suggested that the batch effect of merged data was successfully removed (<xref ref-type="fig" rid="F2">Figure 2</xref>). After algorithm execution, all samples were enrolled with a CIBERSORTx output with a <italic>P</italic> &#x0003c; 0.05 according to a previously defined threshold (<xref ref-type="supplementary-material" rid="TS1">Supplementary Tables S1</xref>, <xref ref-type="supplementary-material" rid="TS2">S2</xref>). The distribution of immune cells is shown in a heatmap (<xref ref-type="fig" rid="F3">Figure 3A</xref>) and barplot (<xref ref-type="fig" rid="F3">Figure 3B</xref>), indicating that many were significantly altered among groups. The Wilcoxon test revealed that the innate immune system showed a higher fraction of resting DCs, macrophages (M0 and M1), activated mast cells, and neutrophils in CD and a lower fraction of M2 macrophages, resting mast cells, and &#x003b3;&#x003b4;T cells in CD patients (<italic>P</italic> &#x0003c; 0.05), whereas in the adaptive immune system, resting NK cells, plasma cells, and CD4 memory T cells (activated and resting) were more prominent in CD, whereas a decreased proportion of activated NK cells, memory B cells, CD8 T cells, follicular helper T cells, and regulatory T cells (Tregs) were observed (<italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Flow chart of the analyses used in this study.</p></caption><graphic xlink:href="fgene-11-00423-g001"/></fig><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Data preprocessing of the derivation cohort. Box plot and principal component analysis showing the overall profiles of GSE112366 and GSE75214 <bold>(A,B)</bold> before and <bold>(C,D)</bold> after normalization. The results confirmed removal of the batch effect PCA.</p></caption><graphic xlink:href="fgene-11-00423-g002"/></fig><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Distribution of immune cells between CD patients and healthy controls using CIBERSORTx for all eligible samples in the derivation cohort. <bold>(A)</bold> Heatmap of the normalized absolute abundance for each cell type in individual samples. <bold>(B)</bold> Barplot of different the fractions of immune cells in individual samples.</p></caption><graphic xlink:href="fgene-11-00423-g003"/></fig><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Boxplot of comparisons of immune-cell proportion between CD patients and healthy controls in the derivation cohort. The red boxplot represents CD patients, and the blue boxplot represents healthy controls. The fraction of resting DCs, macrophages (M0 and M1), activated mast cells, and neutrophils were higher in CD patients, whereas the fraction of M2 macrophages, resting mast cells, and &#x003b3;&#x003b4;T cells were lower in CD patients. The number of resting NK cells, plasma cells, CD4 memory T cells (activated and resting) were elevated in CD, whereas that of activated NK cells, memory B cells, CD8 T cells, follicular helper T cells, and Tregs was lower. *<italic>p</italic> &#x0003c; 0.05, **<italic>p</italic> &#x0003c; 0.01, ***<italic>p</italic> &#x0003c; 0.001.</p></caption><graphic xlink:href="fgene-11-00423-g004"/></fig></sec><sec id="S3.SS2"><title>Functional Enrichment Analysis of DEGs and Identification of Hub Genes</title><p>Based on predefined cut-off criteria, we obtained 150 DEGs, including 70 upregulated genes and 80 downregulated genes, from a total of 17,689 genes in derivation cohort (<xref ref-type="fig" rid="F5">Figure 5A</xref> and <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure S1</xref>). GO enrichment analysis revealed that DEGs were primarily related to the immune response (e.g., leukocyte migration, response to molecules of bacterial origin, organic anion transport, response to lipopolysaccharide, neutrophil migration, and cytokine activity) (<xref ref-type="fig" rid="F5">Figure 5B</xref>). KEGG enrichment analysis demonstrated that DEGs were mainly enriched in pathways related to immunity, such as interleukin (IL)-17 signaling, nucleotide-binding oligomerization domain (NOD)-like receptor signaling, tumor necrosis factor (TNF) signaling, chemokine signaling (<xref ref-type="fig" rid="F5">Figure 5C</xref>). The interactions among 150 DEGs were visualized in the PPI network, which was constructed using an online database (version: 11.0). We identified 145 nodes and 536 edges among the DEGs and used Cytoscape for visualization (<xref ref-type="fig" rid="F5">Figure 5D</xref>). Genes with the top 15 scores based on Cytohubba analysis were identified as hub genes (<xref ref-type="fig" rid="F5">Figure 5E</xref> and <xref rid="T1" ref-type="table">Table 1</xref>) and the expression distribution of the hub genes is shown as a heatmap (<xref ref-type="fig" rid="F5">Figure 5F</xref>). Among the identified genes, both C-X-C chemokine ligand 8 (CXCL8) and IL-1B showed the highest degrees of interaction; therefore, we considered these as potentially crucial genes in CD pathogenesis.</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>DEGs identified in the derivation cohort. <bold>(A)</bold> Volcano plot of DEGs. Red dots represent relatively upregulated genes and green dots represent downregulated genes. Black dots represent genes showing no significant alteration. There were 150 DEGs, including 70 upregulated and 80 downregulated genes among 17,689 genes. Bubble plot of <bold>(B)</bold> Gene Ontology and <bold>(C)</bold> KEGG enrichment analyses. <bold>(D)</bold> Cytoscape software was used for the analysis. <bold>(E)</bold> Hub genes with the top 15 degrees of interaction were identified using Cytohubba plugin. <bold>(F)</bold> Heatmap of the hub genes. BP, biological process; CC, cellular component; MF, molecular function.</p></caption><graphic xlink:href="fgene-11-00423-g005"/></fig><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>The expression analysis of the top 15 hub genes with the highest interaction degree.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Gene symbol</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>LogFC</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>. Value</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Adj. <italic>P</italic>. Value</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Degree</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">CXCL8</td><td valign="top" align="center" rowspan="1" colspan="1">1.573168</td><td valign="top" align="center" rowspan="1" colspan="1">6.38E-10</td><td valign="top" align="center" rowspan="1" colspan="1">4.41E-08</td><td valign="top" align="center" rowspan="1" colspan="1">34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IL1B</td><td valign="top" align="center" rowspan="1" colspan="1">2.037914</td><td valign="top" align="center" rowspan="1" colspan="1">1.02E-11</td><td valign="top" align="center" rowspan="1" colspan="1">1.60E-09</td><td valign="top" align="center" rowspan="1" colspan="1">34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CCL2</td><td valign="top" align="center" rowspan="1" colspan="1">1.189715</td><td valign="top" align="center" rowspan="1" colspan="1">4.87E-08</td><td valign="top" align="center" rowspan="1" colspan="1">1.49E-06</td><td valign="top" align="center" rowspan="1" colspan="1">29</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CXCL11</td><td valign="top" align="center" rowspan="1" colspan="1">1.216482</td><td valign="top" align="center" rowspan="1" colspan="1">1.01E-06</td><td valign="top" align="center" rowspan="1" colspan="1">1.70E-05</td><td valign="top" align="center" rowspan="1" colspan="1">28</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PTGS2</td><td valign="top" align="center" rowspan="1" colspan="1">1.105027</td><td valign="top" align="center" rowspan="1" colspan="1">1.64E-06</td><td valign="top" align="center" rowspan="1" colspan="1">2.57E-05</td><td valign="top" align="center" rowspan="1" colspan="1">25</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CXCL10</td><td valign="top" align="center" rowspan="1" colspan="1">1.185171</td><td valign="top" align="center" rowspan="1" colspan="1">3.02E-06</td><td valign="top" align="center" rowspan="1" colspan="1">4.20E-05</td><td valign="top" align="center" rowspan="1" colspan="1">22</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">APOB</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.95788</td><td valign="top" align="center" rowspan="1" colspan="1">9.08E-06</td><td valign="top" align="center" rowspan="1" colspan="1">0.000103</td><td valign="top" align="center" rowspan="1" colspan="1">20</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TIMP1</td><td valign="top" align="center" rowspan="1" colspan="1">1.178994</td><td valign="top" align="center" rowspan="1" colspan="1">1.82E-08</td><td valign="top" align="center" rowspan="1" colspan="1">6.87E-07</td><td valign="top" align="center" rowspan="1" colspan="1">19</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">LCN2</td><td valign="top" align="center" rowspan="1" colspan="1">2.422802</td><td valign="top" align="center" rowspan="1" colspan="1">4.46E-16</td><td valign="top" align="center" rowspan="1" colspan="1">5.63E-13</td><td valign="top" align="center" rowspan="1" colspan="1">19</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">DPP4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.02179</td><td valign="top" align="center" rowspan="1" colspan="1">2.30E-06</td><td valign="top" align="center" rowspan="1" colspan="1">3.37E-05</td><td valign="top" align="center" rowspan="1" colspan="1">19</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CXCL9</td><td valign="top" align="center" rowspan="1" colspan="1">1.274086</td><td valign="top" align="center" rowspan="1" colspan="1">1.43E-06</td><td valign="top" align="center" rowspan="1" colspan="1">2.28E-05</td><td valign="top" align="center" rowspan="1" colspan="1">18</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SLC2A2</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.27104</td><td valign="top" align="center" rowspan="1" colspan="1">1.10E-05</td><td valign="top" align="center" rowspan="1" colspan="1">0.00012</td><td valign="top" align="center" rowspan="1" colspan="1">17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CXCL5</td><td valign="top" align="center" rowspan="1" colspan="1">1.115601</td><td valign="top" align="center" rowspan="1" colspan="1">3.04E-06</td><td valign="top" align="center" rowspan="1" colspan="1">4.22E-05</td><td valign="top" align="center" rowspan="1" colspan="1">17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">APOA4</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.45209</td><td valign="top" align="center" rowspan="1" colspan="1">1.03E-05</td><td valign="top" align="center" rowspan="1" colspan="1">0.000114</td><td valign="top" align="center" rowspan="1" colspan="1">17</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">IL1RN</td><td valign="top" align="center" rowspan="1" colspan="1">1.191117</td><td valign="top" align="center" rowspan="1" colspan="1">1.32E-08</td><td valign="top" align="center" rowspan="1" colspan="1">5.18E-07</td><td valign="top" align="center" rowspan="1" colspan="1">17</td></tr></tbody></table></table-wrap></sec><sec id="S3.SS3"><title>Identification of CD-Associated Pathways via GSEA and GSVA</title><p>GSEA results showed that genes in the disease group were significant highly enriched in 12 pathways, with only one pathway enriched in the healthy group (<italic>P</italic> &#x0003c; 0.05) (<xref ref-type="fig" rid="F6">Figure 6A</xref> and <xref ref-type="supplementary-material" rid="FS2">Supplementary Figure S2</xref>). Similarly, 10 pathways were significantly activated in CD, whereas two were inhibited according to GSVA results (<xref ref-type="fig" rid="F6">Figure 6B</xref>). Five pathways (&#x0201c;Proteasome,&#x0201d; &#x0201c;Pathogenic Escherichia coli infection,&#x0201d; &#x0201c;NOD-like receptor signaling pathway,&#x0201d; &#x0201c;Drug metabolism cytochrome p450,&#x0201d; and &#x0201c;Systemic lupus erythematosus&#x0201d;) overlapped in both GSEA and GSVA results and were chosen for further correlation analysis (<xref rid="T2" ref-type="table">Table 2</xref>). However, only the NOD-like receptor signaling pathway was identified in the former KEGG pathway enrichment results for the DEGs.</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>GSEA and GSVA results from the derivation cohort. <bold>(A)</bold> GSEA revealed that most of the enriched pathways (<italic>P</italic> &#x0003c; 0.05) correlated with CD. <bold>(B)</bold> GSVA showed that most of the significantly altered pathways were activated in CD.</p></caption><graphic xlink:href="fgene-11-00423-g006"/></fig><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p>The pathways overlapped in results of GSEA and GSVA.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Pathway</bold></td><td valign="top" align="center" colspan="2" rowspan="1"><bold>GSEA</bold></td><td valign="top" align="center" colspan="2" rowspan="1"><bold>GSVA</bold></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" colspan="4" rowspan="1"><hr/></td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1"><bold>NES</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>. Val</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>logFC</bold></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Adj. P. Val</bold></td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">KEGG_PROTEASOME</td><td valign="top" align="center" rowspan="1" colspan="1">1.84</td><td valign="top" align="center" rowspan="1" colspan="1">0.010</td><td valign="top" align="center" rowspan="1" colspan="1">0.3942</td><td valign="top" align="center" rowspan="1" colspan="1">6.21E-08</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KEGG_PATHOGENIC_ESCHE</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">RICHIA_COLI_INFECTION</td><td valign="top" align="center" rowspan="1" colspan="1">1.43</td><td valign="top" align="center" rowspan="1" colspan="1">0.049</td><td valign="top" align="center" rowspan="1" colspan="1">0.236553</td><td valign="top" align="center" rowspan="1" colspan="1">1.22E-05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KEGG_NOD_LIKE_RECEPTOR_</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">SIGNALING_PATHWAY</td><td valign="top" align="center" rowspan="1" colspan="1">1.62</td><td valign="top" align="center" rowspan="1" colspan="1">0.004</td><td valign="top" align="center" rowspan="1" colspan="1">0.217978</td><td valign="top" align="center" rowspan="1" colspan="1">1.76E-05</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KEGG_DRUG_METABOLISM_</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CYTOCHROME_P450</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;1.41</td><td valign="top" align="center" rowspan="1" colspan="1">0.044</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.23917</td><td valign="top" align="center" rowspan="1" colspan="1">0.000208</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">KEGG_SYSTEMIC_LUPUS_</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">ERYTHEMATOSUS</td><td valign="top" align="center" rowspan="1" colspan="1">1.60</td><td valign="top" align="center" rowspan="1" colspan="1">0.013</td><td valign="top" align="center" rowspan="1" colspan="1">0.206671</td><td valign="top" align="center" rowspan="1" colspan="1">0.001946</td></tr></tbody></table></table-wrap></sec><sec id="S3.SS4"><title>Co-expression Analysis and Variable Selection</title><p>To identify co-expression patterns among significantly altered immune cells, hub genes, and signaling pathways, we performed Spearman correlation analysis to evaluate possible relationships (<xref ref-type="fig" rid="F7">Figure 7A</xref> and <xref ref-type="supplementary-material" rid="TS3">Supplementary Tables S3</xref>, <xref ref-type="supplementary-material" rid="TS4">S4</xref>). The results showed that &#x003b3;&#x003b4;T cells, plasma cells, neutrophils, activated CD4 memory T cells, macrophages (M0 and M1) and activated mast cells showed a positive correlation with most of the genes and signaling pathways, whereas Tregs and CD8 T cells showed a negative correlation with the same. To explore potential regulatory networks, we identified the immune cells with a | correlation coefficient| &#x0003e; 0.3 for CXCL8 and IL-1B levels that showing the highest degrees of interaction in hub genes (<xref ref-type="fig" rid="F7">Figure 7B</xref>). Theses included plasma cells, CD8 T cells, activated CD4 memory T cells, Tregs, macrophages (M0 and M1), activated master cell, and neutrophils, and interestingly, these cells were also correlated with the NOD-like receptor signaling pathway (<xref ref-type="fig" rid="F7">Figure 7C</xref>). These 11 features, including levels of CXCL8 and IL-1B, the NOD-like receptor signaling pathway, and their associated immune cells, were integrated into the LASSO regression model, resulting in six features with non-zero coefficients used for further nomogram construction (<xref ref-type="fig" rid="F7">Figures 7D,E</xref>).</p><fig id="F7" position="float"><label>FIGURE 7</label><caption><p>Co-expression patterns and LASSO regression of the derivation cohort. <bold>(A)</bold> Correlation heatmap showing gene co-expression patterns among significantly altered immune cells, hub genes, and pathways. <bold>(B,C)</bold> Circos plot showing the relationships between immune cells, CXCL8 and IL1-B levels, and the NOD-like signaling pathway (| correlation coefficient| &#x0003e; 0.3). <bold>(D,E)</bold> LASSO regression analysis identified six factors with cross-validation performed to prevent overfitting.</p></caption><graphic xlink:href="fgene-11-00423-g007"/></fig></sec><sec id="S3.SS5"><title>Construction of the Diagnostic Prediction Model</title><p>CXCL8 and IL-1B levels, M1 macrophages, Tregs, CD8 T cells, and plasma cells were incorporated into a multivariable logistic regression model to build a diagnostic prediction model for CD and presented as a nomogram (<xref ref-type="fig" rid="F8">Figure 8A</xref>). The area under the ROC analysis for this model is 0.915 (<xref ref-type="fig" rid="F8">Figure 8B</xref>), and the calibration curve showed that the model agreed well between the actual and predicted probability of CD occurrence (<xref ref-type="fig" rid="F8">Figure 8B</xref>). The C-index of the nomogram for predicting CD occurrence was 0.915 [95% confidence interval (CI): 0.875&#x02013;0.955]. Moreover, the Pearson residuals plot showed that the relationship between residuals and predictors was nearly linear without curvature (<xref ref-type="supplementary-material" rid="FS6">Supplementary Figure S6A</xref>).</p><fig id="F8" position="float"><label>FIGURE 8</label><caption><p>Logistic regression analyses of both the derivation and validation cohorts. <bold>(A)</bold> Nomogram predicting CD probability. <bold>(B)</bold> ROC curve and <bold>(C)</bold> calibration curve of the model from derivation cohort. <bold>(D)</bold> ROC curve and <bold>(E)</bold> the calibration curve of the model from validation cohort.</p></caption><graphic xlink:href="fgene-11-00423-g008"/></fig></sec><sec id="S3.SS6"><title>Validation of the Diagnostic Model</title><p>The validation cohort contained a total of 193 CD tissue samples and 83 normal bowel tissue samples. The batch effect of the merged data was successfully removed and visualized using the same method used for the derivation cohort (<xref ref-type="supplementary-material" rid="FS3">Supplementary Figure S3</xref>), and DEG and CIBERSORTx results were similar to those of the derivation cohort (<xref ref-type="supplementary-material" rid="FS4">Supplementary Figures S4</xref>, <xref ref-type="supplementary-material" rid="FS5">S5</xref>). The area under the ROC analysis for this model was 0.884 (<xref ref-type="fig" rid="F8">Figure 8D</xref>), and the calibration curve showed that the model in the validation cohort also agreed well between the probabilities of actual and predicted CD occurrence (<xref ref-type="fig" rid="F8">Figure 8E</xref>). The C-index of the validation model predicting CD occurrence was 0.884 (95% confidence interval: 0.843&#x02013;0.924). Furthermore, the trend of Pearson residuals plot was similar to that from derivation cohort (<xref ref-type="supplementary-material" rid="FS6">Supplementary Figure S6B</xref>).</p></sec></sec><sec id="S4"><title>Discussion</title><p>CD is one of the major types of IBDs and a chronic relapsing inflammatory process that mainly affects the gastrointestinal tract (<xref rid="B3" ref-type="bibr">Baumgart and Carding, 2007</xref>), with dysregulated immune-cell trafficking in the intestine representing the predominant event in CD pathogenesis (<xref rid="B54" ref-type="bibr">Zundler et al., 2019</xref>). Although previous studies have attempted to elucidate the precise pathological process, few reports have provided an overview of immune-cell alterations in CD. Therefore, we employed bioinformatics analyses as a viable strategy to investigate the profile of immune cells to offer insight into the collective regulatory mechanism of CD.</p><p>We used CIBERSORTx to estimate the fraction of 22 immune cells from the innate and adaptive immune systems in CD patients and healthy controls, and established regulatory co-expression regulatory patterns based on correlation analyses between immune cells, genes, and signaling pathways. Moreover, we generated a predictive diagnostic nomogram revealing good performance using both derivation and validation cohort.</p><p>Our diagnostic model showed that CXCL8 and IL-1B represented hub genes with the highest degree of interaction, suggesting their important role in CD pathogenesis. A well-known function of CXCL8 is neutrophils activation and attraction, based on their recruitment to inflamed intestinal mucosa during the early stage of the inflammatory response (<xref rid="B17" ref-type="bibr">Kolaczkowska and Kubes, 2013</xref>; <xref rid="B34" ref-type="bibr">Russo et al., 2014</xref>). Our analysis identified a higher fraction of neutrophils in CD relative to that in normal tissue along with the highest correlation with CXCL8 levels. These results suggested that neutrophils are essential for CD progression; however, whether its role is pathological or beneficial remains controversial. Recently, single-cell analysis revealed that neutrophils recruitment and activation was correlated with clinical disease severity in CD (<xref rid="B40" ref-type="bibr">Therrien et al., 2019</xref>). However, <xref rid="B53" ref-type="bibr">Zhou et al. (2018)</xref> demonstrated that the CD177<sup>+</sup> neutrophils showed a protective effect in IBD through increased anti-bacterial activity and IL-22 production. Therefore, this discrepancy might be due to difference in neutrophils subsets and the phases in which they appear during inflammation.</p><p>IL-1&#x003b2; is an important pro-inflammatory cytokine that promotes the inflammatory process and coordinates autoimmune responses (<xref rid="B20" ref-type="bibr">Ligumsky et al., 1990</xref>). IL-1&#x003b2; is correlated with disease severity, implying essential in pathogenesis of IBD (<xref rid="B23" ref-type="bibr">McAlindon et al., 1998</xref>; <xref rid="B49" ref-type="bibr">Young et al., 2017</xref>). Stimulated by microbe-associated molecular patterns (MAMPs), IL-1&#x003b2; from macrophages, DCs, and epithelial cells induces the development of CD4<sup>+</sup> T cells (<xref rid="B10" ref-type="bibr">de Souza and Fiocchi, 2016</xref>). Moreover, both M1 (pro-inflammatory phenotype) and M2 (pro-resolving phenotype) macrophages are essential for intestinal immune homeostasis (<xref rid="B24" ref-type="bibr">Murray et al., 2014</xref>) with M1 macrophages essential for the antibacterial response that involves proinflammatory cytokines production (i.e., IL-1&#x003b2;) mediate acute inflammation (<xref rid="B47" ref-type="bibr">Wynn et al., 2013</xref>). Therefore, intestinal macrophages dysregulation possibly underlies chronic inflammation associated with IBD due to a lower tolerance of bacteria and food antigens (<xref rid="B10" ref-type="bibr">de Souza and Fiocchi, 2016</xref>). The present study demonstrated an increased proportion of M1 macrophages in CD patients, whereas that of M2 macrophages was lowered. Moreover, we found an increased fraction of CD4<sup>+</sup> memory T cells in CD patients that was positively correlated with IL-1B levels; however, due to limitations with CIBERSORTx analysis, we were unable to investigate subsets of CD4<sup>+</sup> T cell (e.g., CD-specific changes in proportions of T-helper cell).</p><p>However, CIBERSORTx analysis offered an overview of Treg and follicular help T cells (Tfh) status as subsets of CD4 + T cells. The results showed that the fraction of theses cells decreased in CD patients, and that Treg level was an important predictor in the diagnostic model. However, a previous study reported an increased percentage of Tregs as part of CD diagnosis, as well as during the active phase of the disease (<xref rid="B37" ref-type="bibr">Smids et al., 2018</xref>). Tregs generally suppress IL-1B production and inhibit effector T cell proliferation, whereas some studies reported that these function are impaired in CD (<xref rid="B22" ref-type="bibr">Maloy and Powrie, 2011</xref>; <xref rid="B8" ref-type="bibr">Cook et al., 2019</xref>). This suggests that Treg status in CD remains controversial and might depend on inflammatory stage. Another important type of T cell in our diagnostic model was the CD8<sup>+</sup> T cell, which showed a decreased proportion in CD patients. Similar to our results, a previous study reported a decreased response to commensal microbiota by CD8<sup>+</sup> T cells in IBD (<xref rid="B29" ref-type="bibr">Noble et al., 2019</xref>). Because the antigen-presenting function of DCs is critical for the CD8<sup>+</sup> T cell response, the higher percentage of inactivated DCs identified in our analysis might provide a possible explanation. Moreover, another study indicated that polymorphisms of NOD2, which has been widely studied for its strong association with CD, contribute to dysregulated cross-presentation of DCs from CD, ultimately leading to impaired CD8<sup>+</sup> T cell response (<xref rid="B9" ref-type="bibr">Corridoni et al., 2019</xref>). Surprisingly, our results also revealed that the activated NOD-like receptor signaling pathway plays a key role in CD occurrence and is negatively correlated with the CD8<sup>+</sup> T cell levels. Although the NOD-like receptors (NLRs) are essential for the anti-microbial response, defective autophagy due to NOD2 polymorphisms accounts for attenuated bacterial clearance and activation of the downstream nuclear factor kappaB (NF-&#x003ba;B) pathway activation (<xref rid="B43" ref-type="bibr">Travassos et al., 2010</xref>; <xref rid="B32" ref-type="bibr">Plantinga et al., 2011</xref>).</p><p>Notably, reduced CD8 + T cell levels might lead to a skewing toward a humoral immune response, where antibodies are produced by activated B cells (<xref rid="B29" ref-type="bibr">Noble et al., 2019</xref>). Despite the lack of studies targeting the role of B cells in CD, one study identified B cell disruption in CD, including increased levels of plasma cells in lamina propria and altered production of a subclass of antibodies (<xref rid="B4" ref-type="bibr">Brandtzaeg et al., 2006</xref>). Consistent with these findings, our results showed a higher percentage of plasma cells in CD patients relative to healthy controls, with this contributing to the predictions in the nomogram. Additionally, unlike plasma cells, the fraction of na&#x000ef;ve and memory B cells was reduced; however, the exact pathogenic role of B cell distribution remains unclear. A previous study reported that an antibody targeting tumor necrosis factor- &#x003b1; normalized levels of traditional B cells, suggesting the tumor necrosis factor- &#x003b1; as a potential biomarker for treatment monitoring (<xref rid="B41" ref-type="bibr">Timmermans et al., 2016</xref>). Moreover, we found that the reduced levels of &#x003b3;&#x003b4;-T cells in CD tissue comprised only a small proportion of resident lymphocytes. Although previous studies observed similar decreases in the intestinal mucosa, the plasticity of &#x003b3;&#x003b4; T cells make it difficult to elucidate the exact pathogenic role (<xref rid="B6" ref-type="bibr">Catalan-Serra et al., 2017</xref>); therefore, further research is necessary to elucidate the function of &#x003b3;&#x003b4; T cells in CD.</p><p>Our study has some limitations. First, due to the lack of clinical information, including disease phenotype, disease activity status, and CD Activity Index score, associations between immune cells and disease severity could not be well estimated. Second, the score of each factor in the nomogram was derived from gene expression data and an absolute value produced by CIBERSORTx; therefore, our model emphasized the factor itself rather than the value, and a normalization method should be developed for further application of the nomogram. Third, our control included normal intestine tissue. Some diseases that show confusing similarities with CD, including intestinal tuberculosis or Behcet&#x02019;s disease, need to be used for comparison; however, to the best of our knowledge, this was the first study using the CIBERSORTx algorithm to identify the proportion of immune cells in CD and provide novel biomarkers for diagnostic prediction. In future work, molecular biological experiments and/or flow cytometry analyses need to be performed to validate these findings, and another external validation based on a larger sample should be conducted.</p></sec><sec id="S5"><title>Conclusion</title><p>These data offer insight into the landscape of immune cells associated with CD and provide information for a auxiliary diagnosis based on co-expression patterns within an immune-cell cohort specific to CD. The findings demonstrated the cellular and molecular heterogeneity in the disease, and are consistent with previous studies. These results provide novel insight into the cellular and molecular mechanisms underlying CD and facilitate accurate diagnosis of the likelihood of CD.</p></sec><sec sec-type="data-availability" id="S6"><title>Data Availability Statement</title><p>Publicly available datasets were analyzed in this study. The datasets (GSE112366, GSE75214, GSE3365, GSE10616, GSE16879, and GSE102133) provided by Gene Expression Omnibus can be found here: GEO, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>.</p></sec><sec id="S7"><title>AutHor Contributions</title><p>HC designed the experiments, analyzed the data, and wrote the manuscript. CC, XY, WX, MY, and QL designed the experiments and analyzed the data. ZS revised the manuscript. LY devised the concept, designed the research, supervised the study, and wrote the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We would like to thank Mingwei Zhang for giving advice to our study.</p></ack><fn-group><fn id="footnote1"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="https://cibersortx.stanford.edu/">https://cibersortx.stanford.edu/</ext-link></p></fn><fn id="footnote2"><label>2</label><p><ext-link ext-link-type="uri" xlink:href="http://string-db.org">http://string-db.org</ext-link>; version11.0</p></fn><fn id="footnote3"><label>3</label><p><ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/gsea/index.jsp">http://software.broadinstitute.org/gsea/index.jsp</ext-link></p></fn></fn-group><sec id="S9" sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00423/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00423/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="FS1"><label>FIGURE S1</label><caption><p>The heatmap of DEGs from derivation cohort.</p></caption><media xlink:href="Image_1.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS2"><label>FIGURE S2</label><caption><p>The heatmap of GSVA results from derivation cohort.</p></caption><media xlink:href="Image_2.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS3"><label>FIGURE S3</label><caption><p>Data preprocessing of the validation cohort. Box plot and principal component analysis showing the overall profiles of GSE3365, GSE10616, GSE16879, and GSE102133 <bold>(A,B)</bold> before and <bold>(C,D)</bold> after normalization. The results confirmed removal of the batch effect.</p></caption><media xlink:href="Image_3.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS4"><label>FIGURE S4</label><caption><p>The heatmap of DEGs from validation cohort.</p></caption><media xlink:href="Image_4.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS5"><label>FIGURE S5</label><caption><p>Boxplot of comparisons of immune-cell proportion between CD patients and healthy controls in the validation cohort.</p></caption><media xlink:href="Image_5.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="FS6"><label>FIGURE S6</label><caption><p>Pearson plot of the model from derivation cohort <bold>(A)</bold> and validation cohort <bold>(B)</bold>.</p></caption><media xlink:href="Image_6.jpg"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS1"><label>TABLE S1</label><caption><p>The results of CIBERSORTx in Crohn&#x02019;s disease.</p></caption><media xlink:href="Table_1.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS2"><label>TABLE S2</label><caption><p>The results of CIBERSORTx in normal control.</p></caption><media xlink:href="Table_2.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS3"><label>TABLE S3</label><caption><p>The correlation coefficients of co-expression patterns in derivation cohort.</p></caption><media xlink:href="Table_3.XLS"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS4"><label>TABLE S4</label><caption><p>The correlation <italic>P</italic>-value of co-expression patterns in derivation cohort.</p></caption><media xlink:href="Table_4.XLS"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="DS1"><label>DATA SHEET S1</label><caption><p>The R code used in our study.</p></caption><media xlink:href="Data_Sheet_1.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arijs</surname><given-names>I.</given-names></name><name><surname>De Hertogh</surname><given-names>G.</given-names></name><name><surname>Lemaire</surname><given-names>K.</given-names></name><name><surname>Quintens</surname><given-names>R.</given-names></name><name><surname>Van Lommel</surname><given-names>L.</given-names></name><name><surname>Van Steen</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.</article-title>
<source><italic>PLoS One</italic></source>
<volume>4</volume>:<issue>e7984</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007984</pub-id>
<pub-id pub-id-type="pmid">19956723</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T.</given-names></name><name><surname>Wilhite</surname><given-names>S. E.</given-names></name><name><surname>Ledoux</surname><given-names>P.</given-names></name><name><surname>Evangelista</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>I. F.</given-names></name><name><surname>Tomashevsky</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>NCBI GEO: archive for functional genomics data sets&#x02013;update.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>41</volume>
<fpage>D991</fpage>&#x02013;<lpage>D995</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id>
<pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgart</surname><given-names>D. C.</given-names></name><name><surname>Carding</surname><given-names>S. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Inflammatory bowel disease: cause and immunobiology.</article-title>
<source><italic>Lancet</italic></source>
<volume>369</volume>
<fpage>1627</fpage>&#x02013;<lpage>1640</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(07)60750-8</pub-id>
<pub-id pub-id-type="pmid">17499605</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandtzaeg</surname><given-names>P.</given-names></name><name><surname>Carlsen</surname><given-names>H. S.</given-names></name><name><surname>Halstensen</surname><given-names>T. S.</given-names></name></person-group> (<year>2006</year>). <article-title>The B-cell system in inflammatory bowel disease.</article-title>
<source><italic>Adv. Exp. Med. Biol.</italic></source>
<volume>579</volume>
<fpage>149</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1007/0-387-33778-4_10</pub-id>
<pub-id pub-id-type="pmid">16620017</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burczynski</surname><given-names>M. E.</given-names></name><name><surname>Peterson</surname><given-names>R. L.</given-names></name><name><surname>Twine</surname><given-names>N. C.</given-names></name><name><surname>Zuberek</surname><given-names>K. A.</given-names></name><name><surname>Brodeur</surname><given-names>B. J.</given-names></name><name><surname>Casciotti</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Molecular classification of Crohn&#x02019;s disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.</article-title>
<source><italic>J. Mol. Diagn.</italic></source>
<volume>8</volume>
<fpage>51</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.2353/jmoldx.2006.050079</pub-id>
<pub-id pub-id-type="pmid">16436634</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catalan-Serra</surname><given-names>I.</given-names></name><name><surname>Sandvik</surname><given-names>A. K.</given-names></name><name><surname>Bruland</surname><given-names>T.</given-names></name><name><surname>Andreu-Ballester</surname><given-names>J. C.</given-names></name></person-group> (<year>2017</year>). <article-title>Gammadelta T cells in crohn&#x02019;s disease: a new player in the disease pathogenesis?</article-title>
<source><italic>J. Crohns. Colitis</italic></source>
<volume>11</volume>
<fpage>1135</fpage>&#x02013;<lpage>1145</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjx039</pub-id>
<pub-id pub-id-type="pmid">28333360</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>C. H.</given-names></name><name><surname>Chen</surname><given-names>S. H.</given-names></name><name><surname>Wu</surname><given-names>H. H.</given-names></name><name><surname>Ho</surname><given-names>C. W.</given-names></name><name><surname>Ko</surname><given-names>M. T.</given-names></name><name><surname>Lin</surname><given-names>C. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>cytoHubba: identifying hub objects and sub-networks from complex interactome.</article-title>
<source><italic>BMC Syst. Biol.</italic></source>
<volume>8</volume>(<issue>Suppl. 4</issue>):S11. <pub-id pub-id-type="doi">10.1186/1752-0509-8-s4-s11</pub-id>
<pub-id pub-id-type="pmid">25521941</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>L.</given-names></name><name><surname>Stahl</surname><given-names>M.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Nazli</surname><given-names>A.</given-names></name><name><surname>MacDonald</surname><given-names>K. N.</given-names></name><name><surname>Wong</surname><given-names>M. Q.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Suppressive and gut reparative functions of human type 1 T regulatory cells.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>157</volume>
<fpage>1584</fpage>&#x02013;<lpage>1598</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2019.09.002</pub-id>
<pub-id pub-id-type="pmid">31513797</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corridoni</surname><given-names>D.</given-names></name><name><surname>Shiraishi</surname><given-names>S.</given-names></name><name><surname>Chapman</surname><given-names>T.</given-names></name><name><surname>Steevels</surname><given-names>T.</given-names></name><name><surname>Muraro</surname><given-names>D.</given-names></name><name><surname>Thezenas</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>NOD2 and TLR2 Signal via TBK1 and PI31 to direct cross-presentation and CD8 T cell responses.</article-title>
<source><italic>Front. Immunol.</italic></source>
<volume>10</volume>:<issue>958</issue>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00958</pub-id>
<pub-id pub-id-type="pmid">31114588</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname><given-names>H. S.</given-names></name><name><surname>Fiocchi</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Immunopathogenesis of IBD: current state of the art.</article-title>
<source><italic>Nat. Rev. Gastroenterol. Hepatol.</italic></source>
<volume>13</volume>
<fpage>13</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2015.186</pub-id>
<pub-id pub-id-type="pmid">26627550</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feakins</surname><given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines.</article-title>
<source><italic>J. Clin. Pathol.</italic></source>
<volume>66</volume>
<fpage>1005</fpage>&#x02013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1136/jclinpath-2013-201885</pub-id>
<pub-id pub-id-type="pmid">23999270</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuerstein</surname><given-names>J. D.</given-names></name><name><surname>Cheifetz</surname><given-names>A. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Crohn disease: epidemiology.</article-title>
<article-title>Diagnosis, and management.</article-title>
<source><italic>Mayo Clin. Proc.</italic></source>
<volume>92</volume>
<fpage>1088</fpage>&#x02013;<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2017.04.010</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>L.</given-names></name><name><surname>Cope</surname><given-names>L.</given-names></name><name><surname>Bolstad</surname><given-names>B. M.</given-names></name><name><surname>Irizarry</surname><given-names>R. A.</given-names></name></person-group> (<year>2004</year>). <article-title>affy&#x02013;analysis of Affymetrix GeneChip data at the probe level.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>20</volume>
<fpage>307</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btg405</pub-id>
<pub-id pub-id-type="pmid">14960456</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomollon</surname><given-names>F.</given-names></name><name><surname>Dignass</surname><given-names>A.</given-names></name><name><surname>Annese</surname><given-names>V.</given-names></name><name><surname>Tilg</surname><given-names>H.</given-names></name><name><surname>Van Assche</surname><given-names>G.</given-names></name><name><surname>Lindsay</surname><given-names>J. O.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>3rd European evidence-based consensus on the diagnosis and management of crohn&#x02019;s disease 2016: part 1: diagnosis and medical management.</article-title>
<source><italic>J. Crohns Colitis</italic></source>
<volume>11</volume>
<fpage>3</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjw168</pub-id>
<pub-id pub-id-type="pmid">27660341</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanzelmann</surname><given-names>S.</given-names></name><name><surname>Castelo</surname><given-names>R.</given-names></name><name><surname>Guinney</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>GSVA: gene set variation analysis for microarray and RNA-seq data.</article-title>
<source><italic>BMC Bioinformatics</italic></source>
<volume>14</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id>
<pub-id pub-id-type="pmid">23323831</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irizarry</surname><given-names>R. A.</given-names></name><name><surname>Hobbs</surname><given-names>B.</given-names></name><name><surname>Collin</surname><given-names>F.</given-names></name><name><surname>Beazer-Barclay</surname><given-names>Y. D.</given-names></name><name><surname>Antonellis</surname><given-names>K. J.</given-names></name><name><surname>Scherf</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Exploration, normalization, and summaries of high density oligonucleotide array probe level data.</article-title>
<source><italic>Biostatistics</italic></source>
<volume>4</volume>
<fpage>249</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1093/biostatistics/4.2.249</pub-id>
<pub-id pub-id-type="pmid">12925520</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolaczkowska</surname><given-names>E.</given-names></name><name><surname>Kubes</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Neutrophil recruitment and function in health and inflammation.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>13</volume>
<fpage>159</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/nri3399</pub-id>
<pub-id pub-id-type="pmid">23435331</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kugathasan</surname><given-names>S.</given-names></name><name><surname>Baldassano</surname><given-names>R. N.</given-names></name><name><surname>Bradfield</surname><given-names>J. P.</given-names></name><name><surname>Sleiman</surname><given-names>P. M.</given-names></name><name><surname>Imielinski</surname><given-names>M.</given-names></name><name><surname>Guthery</surname><given-names>S. L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.</article-title>
<source><italic>Nat. Genet.</italic></source>
<volume>40</volume>
<fpage>1211</fpage>&#x02013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1038/ng.203</pub-id>
<pub-id pub-id-type="pmid">18758464</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leek</surname><given-names>J. T.</given-names></name><name><surname>Johnson</surname><given-names>W. E.</given-names></name><name><surname>Parker</surname><given-names>H. S.</given-names></name><name><surname>Jaffe</surname><given-names>A. E.</given-names></name><name><surname>Storey</surname><given-names>J. D.</given-names></name></person-group> (<year>2012</year>). <article-title>The sva package for removing batch effects and other unwanted variation in high-throughput experiments.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>28</volume>
<fpage>882</fpage>&#x02013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts034</pub-id>
<pub-id pub-id-type="pmid">22257669</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligumsky</surname><given-names>M.</given-names></name><name><surname>Simon</surname><given-names>P. L.</given-names></name><name><surname>Karmeli</surname><given-names>F.</given-names></name><name><surname>Rachmilewitz</surname><given-names>D.</given-names></name></person-group> (<year>1990</year>). <article-title>Role of interleukin 1 in inflammatory bowel disease&#x02013;enhanced production during active disease.</article-title>
<source><italic>Gut</italic></source>
<volume>31</volume>
<fpage>686</fpage>&#x02013;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1136/gut.31.6.686</pub-id>
<pub-id pub-id-type="pmid">2379873</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. Z.</given-names></name><name><surname>Saito</surname><given-names>S.</given-names></name><name><surname>Morris</surname><given-names>G. F.</given-names></name><name><surname>Miller</surname><given-names>C. A.</given-names><suffix>III</suffix></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Lefante</surname><given-names>J. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis.</article-title>
<source><italic>Genomics</italic></source>
<volume>111</volume>
<fpage>1343</fpage>&#x02013;<lpage>1350</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2018.09.006</pub-id>
<pub-id pub-id-type="pmid">30261315</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maloy</surname><given-names>K. J.</given-names></name><name><surname>Powrie</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Intestinal homeostasis and its breakdown in inflammatory bowel disease.</article-title>
<source><italic>Nature</italic></source>
<volume>474</volume>
<fpage>298</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/nature10208</pub-id>
<pub-id pub-id-type="pmid">21677746</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAlindon</surname><given-names>M. E.</given-names></name><name><surname>Hawkey</surname><given-names>C. J.</given-names></name><name><surname>Mahida</surname><given-names>Y. R.</given-names></name></person-group> (<year>1998</year>). <article-title>Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease.</article-title>
<source><italic>Gut</italic></source>
<volume>42</volume>
<fpage>214</fpage>&#x02013;<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1136/gut.42.2.214</pub-id>
<pub-id pub-id-type="pmid">9536946</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>P. J.</given-names></name><name><surname>Allen</surname><given-names>J. E.</given-names></name><name><surname>Biswas</surname><given-names>S. K.</given-names></name><name><surname>Fisher</surname><given-names>E. A.</given-names></name><name><surname>Gilroy</surname><given-names>D. W.</given-names></name><name><surname>Goerdt</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Macrophage activation and polarization: nomenclature and experimental guidelines.</article-title>
<source><italic>Immunity</italic></source>
<volume>41</volume>
<fpage>14</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id>
<pub-id pub-id-type="pmid">25035950</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>M. F.</given-names></name></person-group> (<year>2014</year>). <article-title>Cytokines in inflammatory bowel disease.</article-title>
<source><italic>Nat. Rev. Immunol.</italic></source>
<volume>14</volume>
<fpage>329</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1038/nri3661</pub-id>
<pub-id pub-id-type="pmid">24751956</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>M. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Current and emerging therapeutic targets for IBD.</article-title>
<source><italic>Nat. Rev. Gastroenterol. Hepatol.</italic></source>
<volume>14</volume>
<fpage>269</fpage>&#x02013;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2016.208</pub-id>
<pub-id pub-id-type="pmid">28144028</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>A. M.</given-names></name><name><surname>Liu</surname><given-names>C. L.</given-names></name><name><surname>Green</surname><given-names>M. R.</given-names></name><name><surname>Gentles</surname><given-names>A. J.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Robust enumeration of cell subsets from tissue expression profiles.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>12</volume>
<fpage>453</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id>
<pub-id pub-id-type="pmid">25822800</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>A. M.</given-names></name><name><surname>Steen</surname><given-names>C. B.</given-names></name><name><surname>Liu</surname><given-names>C. L.</given-names></name><name><surname>Gentles</surname><given-names>A. J.</given-names></name><name><surname>Chaudhuri</surname><given-names>A. A.</given-names></name><name><surname>Scherer</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>37</volume>
<fpage>773</fpage>&#x02013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0114-2</pub-id>
<pub-id pub-id-type="pmid">31061481</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>A.</given-names></name><name><surname>Durant</surname><given-names>L.</given-names></name><name><surname>Hoyles</surname><given-names>L.</given-names></name><name><surname>McCartney</surname><given-names>A. L.</given-names></name><name><surname>Man</surname><given-names>R.</given-names></name><name><surname>Segal</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Deficient resident memory T-Cell and Cd8 T-Cell response to commensals in inflammatory bowel disease.</article-title>
<source><italic>J. Crohns Colitis</italic></source> jjz175. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjz175</pub-id>
<pub-id pub-id-type="pmid">31665283</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panousis</surname><given-names>N. I.</given-names></name><name><surname>Bertsias</surname><given-names>G. K.</given-names></name><name><surname>Ongen</surname><given-names>H.</given-names></name><name><surname>Gergianaki</surname><given-names>I.</given-names></name><name><surname>Tektonidou</surname><given-names>M. G.</given-names></name><name><surname>Trachana</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity.</article-title>
<source><italic>Ann. Rheum Dis.</italic></source>
<volume>78</volume>
<fpage>1079</fpage>&#x02013;<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2018-214379</pub-id>
<pub-id pub-id-type="pmid">31167757</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Cai</surname><given-names>C.</given-names></name><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>An immune infiltration signature to predict the overall survival of patients with colon cancer.</article-title>
<source><italic>IUBMB Life</italic></source>
<volume>71</volume>
<fpage>1760</fpage>&#x02013;<lpage>1770</lpage>. <pub-id pub-id-type="doi">10.1002/iub.2124</pub-id>
<pub-id pub-id-type="pmid">31301220</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantinga</surname><given-names>T. S.</given-names></name><name><surname>Crisan</surname><given-names>T. O.</given-names></name><name><surname>Oosting</surname><given-names>M.</given-names></name><name><surname>van de Veerdonk</surname><given-names>F. L.</given-names></name><name><surname>de Jong</surname><given-names>D. J.</given-names></name><name><surname>Philpott</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Crohn&#x02019;s disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.</article-title>
<source><italic>Gut</italic></source>
<volume>60</volume>
<fpage>1229</fpage>&#x02013;<lpage>1235</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2010.228908</pub-id>
<pub-id pub-id-type="pmid">21406388</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>M. E.</given-names></name><name><surname>Phipson</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Law</surname><given-names>C. W.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>43</volume>:<issue>e47</issue>. <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id>
<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>R. C.</given-names></name><name><surname>Garcia</surname><given-names>C. C.</given-names></name><name><surname>Teixeira</surname><given-names>M. M.</given-names></name><name><surname>Amaral</surname><given-names>F. A.</given-names></name></person-group> (<year>2014</year>). <article-title>The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.</article-title>
<source><italic>Expert Rev. Clin. Immunol.</italic></source>
<volume>10</volume>
<fpage>593</fpage>&#x02013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1586/1744666x.2014.894886</pub-id>
<pub-id pub-id-type="pmid">24678812</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P.</given-names></name><name><surname>Markiel</surname><given-names>A.</given-names></name><name><surname>Ozier</surname><given-names>O.</given-names></name><name><surname>Baliga</surname><given-names>N. S.</given-names></name><name><surname>Wang</surname><given-names>J. T.</given-names></name><name><surname>Ramage</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks.</article-title>
<source><italic>Genome Res.</italic></source>
<volume>13</volume>
<fpage>2498</fpage>&#x02013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
<pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Orr</surname><given-names>S. S.</given-names></name><name><surname>Gaujoux</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Computational deconvolution: extracting cell type-specific information from heterogeneous samples.</article-title>
<source><italic>Curr. Opin. Immunol.</italic></source>
<volume>25</volume>
<fpage>571</fpage>&#x02013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1016/j.coi.2013.09.015</pub-id>
<pub-id pub-id-type="pmid">24148234</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smids</surname><given-names>C.</given-names></name><name><surname>Horjus Talabur Horje</surname><given-names>C. S.</given-names></name><name><surname>Drylewicz</surname><given-names>J.</given-names></name><name><surname>Roosenboom</surname><given-names>B.</given-names></name><name><surname>Groenen</surname><given-names>M. J. M.</given-names></name><name><surname>van Koolwijk</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Intestinal T cell profiling in inflammatory bowel disease: linking T Cell subsets to disease activity and disease course.</article-title>
<source><italic>J. Crohns Colitis</italic></source>
<volume>12</volume>
<fpage>465</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjx160</pub-id>
<pub-id pub-id-type="pmid">29211912</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A.</given-names></name><name><surname>Tamayo</surname><given-names>P.</given-names></name><name><surname>Mootha</surname><given-names>V. K.</given-names></name><name><surname>Mukherjee</surname><given-names>S.</given-names></name><name><surname>Ebert</surname><given-names>B. L.</given-names></name><name><surname>Gillette</surname><given-names>M. A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>102</volume>
<fpage>15545</fpage>&#x02013;<lpage>15550</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
<pub-id pub-id-type="pmid">16199517</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D.</given-names></name><name><surname>Gable</surname><given-names>A. L.</given-names></name><name><surname>Lyon</surname><given-names>D.</given-names></name><name><surname>Junge</surname><given-names>A.</given-names></name><name><surname>Wyder</surname><given-names>S.</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>47</volume>
<fpage>D607</fpage>&#x02013;<lpage>D613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
<pub-id pub-id-type="pmid">30476243</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Therrien</surname><given-names>A.</given-names></name><name><surname>Chapuy</surname><given-names>L.</given-names></name><name><surname>Bsat</surname><given-names>M.</given-names></name><name><surname>Rubio</surname><given-names>M.</given-names></name><name><surname>Bernard</surname><given-names>G.</given-names></name><name><surname>Arslanian</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Recruitment of activated neutrophils correlates with disease severity in adult Crohn&#x02019;s disease.</article-title>
<source><italic>Clin. Exp. Immunol.</italic></source>
<volume>195</volume>
<fpage>251</fpage>&#x02013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1111/cei.13226</pub-id>
<pub-id pub-id-type="pmid">30347439</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmermans</surname><given-names>W. M.</given-names></name><name><surname>van Laar</surname><given-names>J. A.</given-names></name><name><surname>van der Houwen</surname><given-names>T. B.</given-names></name><name><surname>Kamphuis</surname><given-names>L. S.</given-names></name><name><surname>Bartol</surname><given-names>S. J.</given-names></name><name><surname>Lam</surname><given-names>K. H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>B-Cell dysregulation in Crohn&#x02019;s disease is partially restored with infliximab therapy.</article-title>
<source><italic>PLoS One</italic></source>
<volume>11</volume>:<issue>e0160103</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160103</pub-id>
<pub-id pub-id-type="pmid">27468085</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>J.</given-names></name><name><surname>Mehandru</surname><given-names>S.</given-names></name><name><surname>Colombel</surname><given-names>J. F.</given-names></name><name><surname>Peyrin-Biroulet</surname><given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>Crohn&#x02019;s disease.</article-title>
<source><italic>Lancet</italic></source>
<volume>389</volume>
<fpage>1741</fpage>&#x02013;<lpage>1755</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(16)31711-1</pub-id>
<pub-id pub-id-type="pmid">27914655</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travassos</surname><given-names>L. H.</given-names></name><name><surname>Carneiro</surname><given-names>L. A.</given-names></name><name><surname>Ramjeet</surname><given-names>M.</given-names></name><name><surname>Hussey</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>Y. G.</given-names></name><name><surname>Magalhaes</surname><given-names>J. G.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry.</article-title>
<source><italic>Nat. Immunol.</italic></source>
<volume>11</volume>
<fpage>55</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1823</pub-id>
<pub-id pub-id-type="pmid">19898471</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vancamelbeke</surname><given-names>M.</given-names></name><name><surname>Vanuytsel</surname><given-names>T.</given-names></name><name><surname>Farre</surname><given-names>R.</given-names></name><name><surname>Verstockt</surname><given-names>S.</given-names></name><name><surname>Ferrante</surname><given-names>M.</given-names></name><name><surname>Van Assche</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Genetic and transcriptomic bases of intestinal epithelial barrier dysfunction in inflammatory bowel disease.</article-title>
<source><italic>Inflamm. Bowel Dis.</italic></source>
<volume>23</volume>
<fpage>1718</fpage>&#x02013;<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1097/mib.0000000000001246</pub-id>
<pub-id pub-id-type="pmid">28885228</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanDussen</surname><given-names>K. L.</given-names></name><name><surname>Stojmirovic</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>T. C.</given-names></name><name><surname>Kimes</surname><given-names>P. K.</given-names></name><name><surname>Muegge</surname><given-names>B. D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>abnormal small intestinal epithelial microvilli in patients with crohn&#x02019;s disease.</article-title>
<source><italic>Gastroenterology</italic></source>
<volume>155</volume>
<fpage>815</fpage>&#x02013;<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2018.05.028</pub-id>
<pub-id pub-id-type="pmid">29782846</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verstockt</surname><given-names>S.</given-names></name><name><surname>De Hertogh</surname><given-names>G.</given-names></name><name><surname>Van der Goten</surname><given-names>J.</given-names></name><name><surname>Verstockt</surname><given-names>B.</given-names></name><name><surname>Vancamelbeke</surname><given-names>M.</given-names></name><name><surname>Machiels</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Gene and mirna regulatory networks during different stages of Crohn&#x02019;s Disease.</article-title>
<source><italic>J. Crohns Colitis</italic></source>
<volume>13</volume>
<fpage>916</fpage>&#x02013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1093/ecco-jcc/jjz007</pub-id>
<pub-id pub-id-type="pmid">30657881</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>T. A.</given-names></name><name><surname>Chawla</surname><given-names>A.</given-names></name><name><surname>Pollard</surname><given-names>J. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Macrophage biology in development, homeostasis and disease.</article-title>
<source><italic>Nature</italic></source>
<volume>496</volume>
<fpage>445</fpage>&#x02013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1038/nature12034</pub-id>
<pub-id pub-id-type="pmid">23619691</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Xi</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma.</article-title>
<source><italic>J. Trans.l Med.</italic></source>
<volume>17</volume>:<issue>217</issue>. <pub-id pub-id-type="doi">10.1186/s12967-019-1964-6</pub-id>
<pub-id pub-id-type="pmid">31286969</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>R. S.</given-names></name><name><surname>Wiles</surname><given-names>B. M.</given-names></name><name><surname>McGee</surname><given-names>D. W.</given-names></name></person-group> (<year>2017</year>). <article-title>IL-22 Enhances TNF-alpha- and IL-1-Induced CXCL8 responses by intestinal epithelial cell lines.</article-title>
<source><italic>Inflammation</italic></source>
<volume>40</volume>
<fpage>1726</fpage>&#x02013;<lpage>1734</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-017-0614-5</pub-id>
<pub-id pub-id-type="pmid">28656529</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>L. G.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>Q. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters.</article-title>
<source><italic>Omics</italic></source>
<volume>16</volume>
<fpage>284</fpage>&#x02013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
<pub-id pub-id-type="pmid">22455463</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>E.</given-names></name><name><surname>Dai</surname><given-names>F.</given-names></name><name><surname>Mao</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Ma</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Differences of the immune cell landscape between normal and tumor tissue in human prostate.</article-title>
<source><italic>Clin. Transl. Oncol.</italic></source>
<volume>22</volume>
<fpage>344</fpage>&#x02013;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1007/s12094-019-02128-5</pub-id>
<pub-id pub-id-type="pmid">31077088</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name></person-group> (<year>2016</year>). <article-title>Residuals and regression diagnostics: focusing on logistic regression.</article-title>
<source><italic>Ann. Transl. Med.</italic></source>
<volume>4</volume>:<issue>195</issue>. <pub-id pub-id-type="doi">10.21037/atm.2016.03.36</pub-id>
<pub-id pub-id-type="pmid">27294091</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>T.</given-names></name><name><surname>Miao</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>CD177(+) neutrophils as functionally activated neutrophils negatively regulate IBD.</article-title>
<source><italic>Gut</italic></source>
<volume>67</volume>
<fpage>1052</fpage>&#x02013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2016-313535</pub-id>
<pub-id pub-id-type="pmid">28468761</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zundler</surname><given-names>S.</given-names></name><name><surname>Becker</surname><given-names>E.</given-names></name><name><surname>Schulze</surname><given-names>L. L.</given-names></name><name><surname>Neurath</surname><given-names>M. F.</given-names></name></person-group> (<year>2019</year>). <article-title>Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances.</article-title>
<source><italic>Gut</italic></source>
<volume>68</volume>
<fpage>1688</fpage>&#x02013;<lpage>1700</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2018-317977</pub-id>
<pub-id pub-id-type="pmid">31127023</pub-id></mixed-citation></ref></ref-list></back></article>